C F Yazbeck

Suggest Changes
Learn More
OBJECTIVE To evaluate the contribution of preoperative serum tumor markers to manage borderline ovarian tumors (BOT). STUDY DESIGN Retrospective multicentre study including 317 BOT. Serum tumor(More)
  • 1